Document Detail


Pharmacist care plans and documentation of follow-up before the Iowa Pharmaceutical Case Management program.
MedLine Citation:
PMID:  15191245     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To document drug therapy problems and their causes and assess pharmacist follow-up of patients with identified drug therapy problems. DESIGN: Cross-sectional analysis. SETTING: Iowa. PARTICIPANTS: 160 pharmacists who submitted 754 pharmaceutical care plans in an effort to qualify for participation in the Iowa Pharmaceutical Case Management program. INTERVENTIONS AND MAIN OUTCOME MEASURES: Care plans were assessed for drug therapy problems and causes and for documentation of pharmacist follow-up (actual, none, or intent to follow up). RESULTS: Pharmacists documented a wide variety of drug therapy problems and causes, including adverse drug reactions (20.1% of care plans), need for additional drug therapy (18.9%), lack of patient adherence to therapy (16.3%), incorrect medication being prescribed (14.1%), and drug dose too high (10.0%). Pharmacist follow-up with patients was not optimal, with 31% of care plans providing documentation of actual follow-up. Another 42.2% of plans indicated that the pharmacist intended to contact the patient for follow-up but either did not do so or did not record the intervention. No actual follow-up or intent to follow up was recorded in 26.8% of care plans. Pharmacists practicing in independent pharmacies followed up with patients more frequently than those in other settings (36.4% of care plans, compared with 22.7%, 23.2%, and 28.4% for chain, clinic, and franchise pharmacies). Pharmacists were more likely to follow up when the identified problem involved drug safety rather than effectiveness (36.2% versus 28.3% of care plans). CONCLUSION: Documentation of pharmacist follow-up with patients was less than optimal. In addition to identifying drug therapy problems and causes, pharmacists must complete the care continuum through documentation of patient monitoring and follow-up to transform the philosophy and vision of the pharmaceutical care concept into a practice of pharmacy recognized and rewarded by patients and payers.
Authors:
CoraLynn Becker; Darrel C Bjornson; Julie W Kuhle
Related Documents :
17991105 - Pathological interactions with the timing of birth and uterine activation.
15054145 - Drug-related problem classification systems.
17973975 - New algorithm for the treatment of gastro-oesophageal reflux disease.
24507385 - A comparison of caregiver burden in older persons and persons with parkinson's disease ...
12851055 - A macro-directive mechanism that facilitates automatic updating and processing of the c...
1168215 - The dietitian and credentialing.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Pharmacists Association : JAPhA     Volume:  44     ISSN:  1544-3191     ISO Abbreviation:  J Am Pharm Assoc (2003)     Publication Date:    2004 May-Jun
Date Detail:
Created Date:  2004-06-11     Completed Date:  2004-06-29     Revised Date:  2007-05-28    
Medline Journal Info:
Nlm Unique ID:  101176252     Medline TA:  J Am Pharm Assoc (2003)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  350-7     Citation Subset:  IM    
Affiliation:
Department of Pharmacy, University of Kansas Medical Center, Kansas City, KS 66160, USA. cbecker@kumc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Case Management / standards*
Cross-Sectional Studies
Documentation*
Drug Therapy* / adverse effects,  standards
Female
Follow-Up Studies
Humans
Iowa
Male
Middle Aged
Pharmacy / standards*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of the Iowa Medicaid pharmaceutical case management program.
Next Document:  Collaborative working relationships between pharmacists and physicians: an exploratory study.